4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-23-021420
Chief Financial Officer sold 347 shares at $15.36 ($5,330)
From the SEC's structured data for this filing
Trades in this filing
Catinazzo Thomas · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-03-27 | Sale : show line 1 in the form | −347 | $15.36 | $5,330 | 150,135 | D |
| Open-market sales · 347 sh · avg $15.36 · $5,330 | ||||||
Loading xslF345X04/doc4.xml…